Sanofi is to buy Principia Biopharma for up to $3.68 billion, adding a potential multiple sclerosis drug to its pipeline. The French pharma said it will pay $100 per share in cash for San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback